Despite significant dips in its vaccines sales, the British pharma narrowly beat consensus estimates for Q4 2024 and raised ...

As the ultra-wealthy prioritize security, they're increasingly demanding sophisticated safety features that make the panic ...

GSK Plc announced a share buyback of £2 billion as it saw better than expected profit in the fourth quarter. The share ...

GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

Emerson Electric (NYSE: EMR), the St. Louis-based industrial technology and software company, unveiled its new corporate ...